1. Home
  2. TARA vs KWM Comparison

TARA vs KWM Comparison

Compare TARA & KWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • KWM
  • Stock Information
  • Founded
  • TARA N/A
  • KWM N/A
  • Country
  • TARA United States
  • KWM Cayman Islands
  • Employees
  • TARA N/A
  • KWM N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • KWM
  • Sector
  • TARA Health Care
  • KWM
  • Exchange
  • TARA Nasdaq
  • KWM NYSE
  • Market Cap
  • TARA 126.5M
  • KWM 241.0M
  • IPO Year
  • TARA N/A
  • KWM N/A
  • Fundamental
  • Price
  • TARA $3.33
  • KWM $3.91
  • Analyst Decision
  • TARA Strong Buy
  • KWM
  • Analyst Count
  • TARA 7
  • KWM 0
  • Target Price
  • TARA $20.67
  • KWM N/A
  • AVG Volume (30 Days)
  • TARA 450.2K
  • KWM 1.0M
  • Earning Date
  • TARA 08-05-2025
  • KWM 01-01-0001
  • Dividend Yield
  • TARA N/A
  • KWM N/A
  • EPS Growth
  • TARA N/A
  • KWM N/A
  • EPS
  • TARA N/A
  • KWM N/A
  • Revenue
  • TARA N/A
  • KWM $678,756.00
  • Revenue This Year
  • TARA N/A
  • KWM N/A
  • Revenue Next Year
  • TARA N/A
  • KWM N/A
  • P/E Ratio
  • TARA N/A
  • KWM N/A
  • Revenue Growth
  • TARA N/A
  • KWM N/A
  • 52 Week Low
  • TARA $1.60
  • KWM $1.52
  • 52 Week High
  • TARA $10.48
  • KWM $8.48
  • Technical
  • Relative Strength Index (RSI)
  • TARA 55.94
  • KWM N/A
  • Support Level
  • TARA $3.25
  • KWM N/A
  • Resistance Level
  • TARA $3.23
  • KWM N/A
  • Average True Range (ATR)
  • TARA 0.17
  • KWM 0.00
  • MACD
  • TARA 0.04
  • KWM 0.00
  • Stochastic Oscillator
  • TARA 81.25
  • KWM 0.00

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About KWM K WAVE MEDIA LTD

K Wave Media Ltd is a company formed for the purpose of entering into a business combination agreement.

Share on Social Networks: